Zai Lab Limited ADR (NASDAQ: ZLAB) on Friday, soared 3.07% from the previous trading day, before settling in for the closing price of $36.18. Within the past 52 weeks, ZLAB’s price has moved between $13.48 and $39.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 118.89% over the last five years. The company achieved an average annual earnings per share of 43.69%. With a float of $108.11 million, this company’s outstanding shares have now reached $109.14 million.
The firm has a total of 1869 workers. Let’s measure their productivity. In terms of profitability, gross margin is 62.94%, operating margin of -70.71%, and the pretax margin is -64.44%.
Zai Lab Limited ADR (ZLAB) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Zai Lab Limited ADR is 0.94%, while institutional ownership is 51.10%. The most recent insider transaction that took place on Mar 17 ’25, was worth 115,230. In this transaction an insider of this company sold 3,000 shares at a rate of $38.41, taking the stock ownership to the 30,834 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Officer proposed sale 3,000 for $38.41, making the entire transaction worth $115,230.
Zai Lab Limited ADR (ZLAB) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.69% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Zai Lab Limited ADR (ZLAB) is currently performing well based on its current performance indicators. A quick ratio of 3.38 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.60, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach 0.24 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Analysing the last 5-days average volume posted by the [Zai Lab Limited ADR, ZLAB], we can find that recorded value of 0.91 million was better than the volume posted last year of 0.89 million. As of the previous 9 days, the stock’s Stochastic %D was 41.43%. Additionally, its Average True Range was 2.01.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 84.45%, which indicates a significant increase from 61.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.94% in the past 14 days, which was lower than the 53.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.69, while its 200-day Moving Average is $25.19. Now, the first resistance to watch is $39.17. This is followed by the second major resistance level at $41.06. The third major resistance level sits at $42.34. If the price goes on to break the first support level at $36.00, it is likely to go to the next support level at $34.72. Should the price break the second support level, the third support level stands at $32.83.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
Market capitalization of the company is 4.07 billion based on 109,628K outstanding shares. Right now, sales total 398,990 K and income totals -257,100 K. The company made 109,070 K in profit during its latest quarter, and -81,680 K in sales during its previous quarter.
